83184-32-1

Upstream product

• 4428-98-2 N-cyanomethanimidic acid ethyl ester 
• 29528-28-7 VUF 5801 

Downstream Products

• 83184-52-5 N-isobutyl-N'-(4-1H-imidazol-4-ylphenyl)formamidine 
• 103298-42-6 N-isopropyl-N-methyl-N'-(4-1H-imidazol-4-ylphenyl)formamidine 
• 83184-45-6 N-allyl-N'-(4-1H-imidazol-4-ylphenyl)formamidine 
• 133777-14-7 N-(1-Ethyl-propyl)-N'-[4-(1H-imidazol-4-yl)-phenyl]-formamidine; hydrochloride 
• 83184-43-4 N-isopropyl-N'-(4-1H-imidazol-4-ylphenyl)formamidine 
• 83184-40-1 N-ethyl-N'-(4-1H-imidazol-4-ylphenyl)formamidine 
• 88304-51-2 N-[4-(1H-Imidazol-4-yl)-phenyl]-formamidine 
• 83184-48-9 N-propyl-N'-(4-1H-imidazol-4-ylphenyl)formamidine 

Relevant academic research and scientific papers

(Imidazolylphenyl)formamidines. A structurally novel class of potent histamine H2 receptor antagonists

Structure-activity considerations of N(α)-guanylhistamine, the first compound found with detectable H2-antagonist activity, led to the synthesis of a series of conformationally rigid guanylhistamine analogues, namely (imidazolylphenyl)guanidine

Imidazolylphenyl amidines, pharmaceutical compositions containing same and use thereof

This invention relates to imidazolylphenyl amidines, the preparation thereof, and pharmaceutical compositions containing them. More particularly, this invention relates to compounds of the general formula STR1 in which R, R1, R3, whi